Note 5 - Stockholders' Deficit (Details) |
9 Months Ended |
---|---|
Mar. 31, 2019
$ / shares
shares
| |
Stockholders' equity (deficit): | |
Warrants outstanding and exercisable, beginning | shares | 1,740,790 |
Warrants issued | shares | 0 |
Warrants forfeited | shares | (1,657,457) |
Warrants outstanding and exercisable, ending | shares | 83,333 |
Warrants outstanding and exercisable, weighted average exercise price, beginning | $ / shares | $ 2.03 |
Warrants issued, weighted average exercise price | $ / shares | 0.00 |
Warrants forfeited, weighted average exercise price | $ / shares | 2.03 |
Warrants outstanding and exercisable, weighted average exercise price, ending | $ / shares | $ 2.00 |
Warrants outstanding and exercisable, remaining contractual term, beginning | 8 months 27 days |
Warrants outstanding and exercisable, remaining contractual term, ending | 6 months |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Represents the weighted average exercise price of warrants or rights. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|